Arrow QuickFlash Catheterization Kit Recall Issued Following Reports of Life-Threatening Blood Vessel Damage

Arrow-Quickflash-Catherization-Kits-Recall

Federal safety officials warn that problems with the guidewire handles on ARROW catheterization kits could lead to serious and potentially life threatening damage to blood vessels, leading to the recall of more than 330,000 devices distributed throughout the United States between December 2021 and January 2024.

The ARROW QuickFlash Catheterization Kits recall was posted by the U.S. Food and Drug Administration (FDA) on April 3, after the manufacturer received reports of at least 194 complaints, including 10 severe injuries and one death that appears to be related to the problem.

The recalled ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits are designed for medical professionals to gain entry into a patient’s peripheral arterial system or smaller blood vessels. However, officials warn that increased resistance in the guidewire handle and chamber during use may lead to severe harm, including damage to the walls of blood vessels, constriction of blood vessels (known as vasospasm), blockages in arteries (embolism), or even fatalities.

Bard PowerPort Lawsuit Lawyers
Bard PowerPort Lawsuit Lawyers

Arrow Quickflash Catherization Kits Recall

This recall affects approximately 334,995 Arrow QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits that were distributed from December 1, 2021, to January 27, 2024.

In a recall letter sent out to medical facilities and distributors on February 12, the manufacturers instructed medical facilities to immediately stop using and distributing the devices and to quarantine any remaining inventory. They advised distributors to provide a copy of the recall letter to customers who have purchased the recall products, and an acknowledgement that must be completed by customers.

Any customers with any questions or concerns are advised to contact Teleflex and Arrow International at their Customer Service Phone: 1-866-396-2111, FAX: 1-855-419-8507 or Email: Recalls@teleflex.com.

The FDA is allowing consumers to report any adverse reactions, side effects, or quality issues encountered during the use of these kits to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.




0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027.
A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications.
Suboxone lawyers will meet today with a federal judge, to discuss the status of thousands of tooth decay lawsuits brought over the opioid treatment film strips.